APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,387 | +1069.7% | 40,641 | +316.9% | 0.03% | +575.0% |
| Q2 2023 | $888 | +38.1% | 9,749 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $643 | +27.6% | 9,749 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $504 | -99.9% | 9,749 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $666,000 | +51.0% | 9,749 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $441,000 | -10.9% | 9,749 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $495,000 | +7.4% | 9,749 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $461,000 | +43.6% | 9,749 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $321,000 | -47.9% | 9,749 | 0.0% | 0.00% | -66.7% |
| Q2 2021 | $616,000 | +47.4% | 9,749 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $418,000 | -25.1% | 9,749 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $558,000 | +89.8% | 9,749 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $294,000 | -7.5% | 9,749 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $318,000 | +21.8% | 9,749 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $261,000 | – | 9,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |